Private Wealth Management Group, LLC Vaxcyte, Inc. Transaction History
Private Wealth Management Group, LLC
- $261 Billion
- Q4 2024
A detailed history of Private Wealth Management Group, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Private Wealth Management Group, LLC holds 43 shares of PCVX stock, worth $3,827. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43
Previous 36
19.44%
Holding current value
$3,827
Previous $4.11 Million
14.44%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PCVX
# of Institutions
355Shares Held
123MCall Options Held
772KPut Options Held
430K-
Vanguard Group Inc Valley Forge, PA11.4MShares$1.02 Billion0.02% of portfolio
-
Janus Henderson Group PLC London, X010.9MShares$972 Million0.67% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$885 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$774 Million13.83% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.9MShares$436 Million0.12% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $5.28B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...